Free fatty acid receptor 2, A candidate target for type 1 diabetes, Induces cell apoptosis through erk signaling

Journal of Molecular Endocrinology

Volumn 53, Issue 3, 2014, Pages 367-380

  Shi, Guojun ^a,b   Sun, Chen ^a,b   Gu, Weiqiong ^a   Yang, Minglan ^a   Zhang, Xiaofang ^a   Zhai, Nan ^a   Lu, Yan ^a   Zhang, Zhijian ^a   Shou, Peishun ^b   Zhang, Zhiguo ^a   Ning, Guang ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Free fatty acid receptor 2; Inflammatory; Peripheral blood mononuclear cells; Short chain fatty acids; Type 1 diabetes

Indexed keywords

ACETANILIDE DERIVATIVE; ACETIC ACID; C PEPTIDE; FATTY ACID RECEPTOR 2; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLACETAMIDE 1; PROTEIN BID; RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1; CELL SURFACE RECEPTOR; G-PROTEIN COUPLED RECEPTOR 43, HUMAN; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BINDING SITE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INTRACELLULAR SIGNALING; LUCIFERASE ASSAY; MACROPHAGE; MALE; NONHUMAN; PANCREAS ISLET; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; GENETIC ASSOCIATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; MCF 7 CELL LINE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC ASSOCIATION STUDIES; HEK293 CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MCF-7 CELLS; MICE; MICE, INBRED C57BL; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 84908365772     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0065     Document Type: Article

References (48)

1. Baines CP, Kaiser RA, Sheiko T, Craigen WJ & Molkentin JD 2007 Voltage-dependent anion channels are dispensable for mitochondrial-depen-dent cell death. Nature Cell Biology 9 550–555. (doi:10.1038/ncb1575)
2. Baumann B, Salem HH & Boehm BO 2012 Anti-inflammatory therapy in type 1 diabetes. Current Diabetes Reports 12 499–509. (doi:10.1007/s11892-012-0299-y)
3. Bellenger J, Bellenger S, Bataille A, Massey KA, Nicolaou A, Rialland M, Tessier C, Kang JX & Narce M 2011 High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 60 1090–1099. (doi:10.2337/db10-0901)
4. Beyan H, Riese H, Hawa MI, Beretta G, Davidson HW, Hutton JC, Burger H, Schlosser M, Snieder H, Boehm BO et al. 2012 Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study. Diabetes 61 1192–1198. (doi:10.2337/db11-0971)
5. Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, Martin JC, Scott KP, Buc Calderon P, Feron O, Muccioli GG et al. 2012 Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. British Journal of Cancer 107 1337–1344. (doi:10.1038/bjc.2012.409)
6. Bindels LB, Dewulf EM & Delzenne NM 2013 GPR43/FFA2: physiopatho-logical relevance and therapeutic prospects. Trends in Pharmacological Sciences 34 226–232. (doi:10.1016/j.tips.2013.02.002)
7. Bjursell M, Admyre T, Goransson M, Marley AE, Smith DM, Oscarsson J & Bohlooly YM 2011 Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. American Journal of Physiology Endocrinology and Metabolism 300 E211–E220. (doi:10.1152/ajpendo.00229.2010)
8. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ et al. 2003 The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. Journal of Biological Chemistry 278 11312–11319. (doi:10.1074/jbc.M211609200)
9. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S & Eizirik DL 2005 Mechanisms of pancreatic b-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (Suppl 2) S97–S107. (doi:10.2337/diabetes.54.suppl_2.S97)
10. Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, Roep BO & von Herrath MG 2012 Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. Journal of Experimental Medicine 209 51–60. (doi:10.1084/jem.20111187)
11. Denis MC, Mahmood U, Benoist C, Mathis D & Weissleder R 2004 Imaging inflammation of the pancreatic islets in type 1 diabetes. PNAS 101 12634–12639. (doi:10.1073/pnas.0404307101)
12. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H & Li Y 2008 Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149 4519–4526. (doi:10.1210/en.2008-0059)
13. 2C uptake in apoptosis. Cell Calcium 40 553–560. (doi:10.1016/j.ceca.2006.08.016)
14. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S & Tsujimoto G 2005 Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine 11 90–94. (doi:10.1038/nm1168)
15. Hong YH, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi KC, Feng DD, Chen C, Lee HG et al. 2005 Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146 5092–5099. (doi:10.1210/en.2005-0545)
16. Jin L, Shi G, Ning G, Li X & Zhang Z 2011 Andrographolide attenuates tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes. Molecular and Cellular Endocrinology 332 134–139. (doi:10.1016/j.mce.2010.10.005)
17. Johnston CS & Gaas CA 2006 Vinegar: medicinal uses and antiglycemic effect. Medscape General Medicine 8 61.
18. Kaji I, Karaki S, Tanaka R & Kuwahara A 2011 Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enter-oendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide. Journal of Molecular Histology 42 27–38. (doi:10.1007/s10735-010-9304-4)
19. Kaufmann T, Tai L, Ekert PG, Huang DC, Norris F, Lindemann RK, Johnstone RW, Dixit VM & Strasser A 2007 The BH3-only protein Bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 129 423–433. (doi:10.1016/j.cell.2007.03.017)
20. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T et al. 2013 The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nature Communications 4 1829. (doi:10.1038/ncomms2852)
21. Kroemer G & Reed JC 2000 Mitochondrial control of cell death. Nature Medicine 6 513–519. (doi:10.1038/74994)
22. Lamhamedi-Cherradi SE, Zheng S, Hilliard BA, Xu L, Sun J, Alsheadat S, Liou HC & Chen YH 2003 Transcriptional regulation of type I diabetes by NF-k B. Journal of Immunology 171 4886–4892. (doi:10.4049/jimmunol.171.9.4886)
23. Layden BT, Angueira AR, Brodsky M, Durai V & Lowe WL Jr 2013 Short chain fatty acids and their receptors: new metabolic targets. Translational Research 161 131–140. (doi:10.1016/j.trsl.2012.10.007)
24. Lee T, Schwandner R, Swaminath G, Weiszmann J, Cardozo M, Greenberg J, Jaeckel P, Ge H, Wang Y, Jiao X et al. 2008 Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Molecular Pharmacology 74 1599–1609. (doi:10.1124/mol.108.049536)
25. Lehuen A, Diana J, Zaccone P & Cooke A 2010 Immune cell crosstalk in type 1 diabetes. Nature Reviews. Immunology 10 501–513. (doi:10.1038/nri2787)
26. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J et al. 2003 Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. Journal of Biological Chemistry 278 25481–25489. (doi:10.1074/jbc.M301403200)
27. Mandrup-Poulsen T, Pickersgill L & Donath MY 2010 Blockade of interleukin 1 in type 1 diabetes mellitus. Nature Reviews. Endocrinology 6 158–166. (doi:10.1038/nrendo.2009.271)
28. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D et al. 2009 Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 1282–1286. (doi:10.1038/nature08530)
29. 2R, expressed on leukocytes and activated by short-chain fatty acids. Biochemical and Biophysical Research Communications 303 1047–1052. (doi:10.1016/S0006-291X(03)00488-1)
30. Nohr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, Sichlau RM, Grunddal KV, Seier Poulsen S, Han S et al. 2013 GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154 3552–3564. (doi:10.1210/en.2013-1142)
31. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, Yanagisawa M et al. 2008 Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. PNAS 105 16767–16772. (doi:10.1073/pnas.0808567105)
32. Schreck R & Baeuerle PA 1990 NF-kB as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Molecular and Cellular Biology 10 1281–1286. (doi:10.1128/MCB.10.3.1281)
33. Sen P, Bhattacharyya S, Wallet M, Wong CP, Poligone B, Sen M, Baldwin AS Jr & Tisch R 2003 NF-kB hyperactivation has differential effects on the APC function of nonobese diabetic mouse macro-phages. Journal of Immunology 170 1770–1780. (doi:10.4049/jimmunol.170.4.1770)
34. Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A et al. 2009 G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. Journal of Immunology 183 7514–7522. (doi:10.4049/jimmunol.0900063)
35. Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP & Leschek E 2005 Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial – type 1. Diabetes Care 28 1068–1076. (doi:10.2337/diacare.28.5.1068)
36. Strom A, Kolb H, Martin S, Herder C, Simon MC, Koenig W, Heise T, Heinemann L, Roden M & Schloot NC 2012 Improved preservation of residual b cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). PLoS ONE 7 e33108. (doi:10.1371/journal.pone.0033108)
37. Tang Y, Chen Y, Jiang H & Nie D 2011a Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death. Cell Death and Differentiation 18 602–618. (doi:10.1038/cdd.2010.117)
38. Tang Y, Chen Y, Jiang H, Robbins GT & Nie D 2011b G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. International Journal of Cancer 128 847–856. (doi:10.1002/ijc.25638)
39. Tisch R & McDevitt H 1996 Insulin-dependent diabetes mellitus. Cell 85 291–297. (doi:10.1016/S0092-8674(00)81106-X)
40. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F & Gribble FM 2012 Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 364–371. (doi:10.2337/db11-1019)
41. Uno S, Imagawa A, Okita K, Sayama K, Moriwaki M, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T et al. 2007 Macrophages and dendritic cells infiltrating islets with or without b cells produce tumour necrosis factor-a in patients with recent-onset type 1 diabetes. Diabetologia 50 596–601. (doi:10.1007/s00125-006-0569-9)
42. Vinolo MA, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly YM, Stephens L, Hawkins PT & Curi R 2011 SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS ONE 6 e21205. (doi:10.1371/journal.pone.0021205)
43. Wada T & Penninger JM 2004 Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23 2838–2849. (doi:10.1038/sj.onc.1207556)
44. Xie QW, Kashiwabara Y & Nathan C 1994 Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. Journal of Biological Chemistry 269 4705–4708.
45. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM & Yanagisawa M 2004 Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. PNAS 101 1045–1050. (doi:10.1073/pnas.2637002100)
46. Yonezawa T, Kobayashi Y & Obara Y 2007 Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/ heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cellular Signalling 19 185–193. (doi:10.1016/j.cellsig.2006.06.004)
47. Zaibi MS, Stocker CJ, O’Dowd J, Davies A, Bellahcene M, Cawthorne MA, Brown AJ, Smith DM & Arch JR 2010 Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Letters 584 2381–2386. (doi:10.1016/j.febslet.2010.04.027)
48. Zhang X, Ye L, Hu J, Tang W, Liu R, Yang M, Hong J, Wang W, Ning G & Gu W 2012 Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient. PLoS ONE 7 e31887. (doi:10.1371/journal.pone.0031887)